Using ErbB2-negative status to direct therapy in locally advanced breast cancer
Cancer Biol Ther
.
2007 Mar;6(3):463-4.
doi: 10.4161/cbt.6.3.4233.
Epub 2007 Mar 20.
Authors
Aaron C Spalding
1
,
Joseph N Contessa
Affiliation
1
Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan 48109, USA.
PMID:
17471028
DOI:
10.4161/cbt.6.3.4233
No abstract available
Publication types
Comment
MeSH terms
Biomarkers, Tumor / analysis*
Breast Neoplasms / diagnosis*
Breast Neoplasms / therapy*
Female
Humans
Prognosis
Receptor, ErbB-2 / analysis*
Substances
Biomarkers, Tumor
Receptor, ErbB-2